Sapiens International Corporation N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPNS research report →
Range $38 – $38
Price Chart
About the company
Sapiens International Corporation N. V. is a global technology provider that develops and supplies software solutions specifically for the insurance and financial services sectors.
- CEO
- Roni Al-Dor
- IPO
- 1998
- Employees
- 4,850
- HQ
- Holon, IL
Get TickerSpark's AI analysis on SPNS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.43B
- P/E
- 52.35
- Fwd P/E
- 27.85
- PEG
- -5.54
- P/S
- 5.65
- P/B
- 4.84
- EV/EBITDA
- 33.43
- Div Yield
- 0.00%
- Gross Margin
- 44.15%
- Op Margin
- 12.97%
- Net Margin
- 10.81%
- ROE
- 9.47%
- ROIC
- 7.37%
Latest fiscal year · YoY change
- Revenue
- $542.38M+5.4%
- Gross Profit
- $244.23M+11.2%
- Op Income
- $91.38M
- Net Income
- $72.18M+15.6%
- EPS
- $1.29+14.2%
- OCF Growth
- +3.5%
- FCF Growth
- +2.9%
- 52W High
- $43.52
- 52W Low
- $23.69
- 50D MA
- $43.17
- 200D MA
- $34.76
- Beta
- 0.90
- RSI (14)
- 70
- Avg Volume
- 505.98K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Sapiens delivered modest Q1 growth with improving recurring mix and raised 2025 guidance, but near-term margins will be pressured by newly announced acquisitions.· May 8, 2025
- Q1 revenue was $136 million, up 1.4% year over year, with ARR up 11.8% to $187 million.
- Gross margin improved to 46.3% from 45.4%, helped by a higher recurring revenue mix; recurring software and post-production services rose 14.7% to $108 million.
- Management raised full-year non-GAAP revenue guidance to $574 million-$578 million and operating profit guidance to $94 million-$96 million.
- Two acquisitions were announced—Candela and Advantage Go—which management said expand Life in APAC and P&C specialty underwriting capabilities.
- Management said cloud adoption is continuing, new logos are largely cloud-based, and life business momentum remains strong in North America and Europe.
Q1 2025 revenue was $136 million, up 1.4% from $134 million in Q1 2024; on a constant-currency basis, revenue would have been $2 million higher. Gross profit was $63 million versus $61 million a year ago, and gross margin was 46.3% compared with 45.4% last year, an increase of 90 basis points. Operating profit was $25 million versus $24 million, operating margin was 18.0% versus 18.1%, net income attributable to shareholders was $21 million versus $20.7 million, and diluted EPS was $0.37 versus $0.36. ARR was $187 million, up 11.8%, recurring software and post-production services revenue rose to $108 million from $94 million, and adjusted free cash flow was $23 million versus $17 million. For 2025, Sapiens raised non-GAAP revenue guidance to $574 million-$578 million and non-GAAP operating profit guidance to $94 million-$96 million; Q2 operating profit is expected to be $20 million-$21 million. Management said the guidance includes an expected aggregate revenue impact of about $21 million at the midpoint from Candela and Advantage Go, and an aggregate profit impact of about negative $5 million at the midpoint. They also said Candela is expected to contribute positively to profit in Q4, while Advantage Go will remain loss-making throughout the year.
Roni Al-Dor said the quarter showed solid execution across regions, with continued momentum in Life, especially North America, and said demand for Sapiens' solutions is building. He emphasized M&A as a key growth lever, saying Candela strengthens Life and APAC and Advantage Go expands P&C and access to the London specialty market. His tone was upbeat and strategic, with repeated focus on cross-sell, cloud adoption, AI, and expanding the global platform.
Roni Giladi walked through the quarter’s financials and highlighted that revenue grew to $136 million, gross margin improved to 46.3%, operating profit reached $25 million, and adjusted free cash flow was $23 million. He also noted cash and cash equivalents plus short-term deposits of $206 million, debt of $20 million, and a $16.8 million dividend paid in April plus a special cash dividend of $0.36 per share, or $20.1 million in total, approved by the board. On guidance, he said revenue is now expected at $574 million-$578 million and operating profit at $94 million-$96 million, but that acquisitions create a short-term pressure point, with about $21 million of incremental revenue and about negative $5 million of profit impact at the midpoint.
Analysts focused on the Advantage Go deal, asking how it accelerates P&C traction in North America and globally and what it means for the model; management said the acquisition addresses rising underwriting workbench demand, supports U.S. and Europe, and gives Sapiens entry into the London market. When asked about the financial impact, management said Advantage Go has about 60% gross margin, slightly above 50% ARR mix, and is expected to grow at double-digit rates next year, but remains loss-making and should turn profitable in 2027. Questions on Life momentum and cloud migration drew comments that Life continues to show strong demand and that nearly all new deals are cloud-based, with customers steadily migrating to cloud each quarter.
The call showed broad-based momentum in Life, solid demand in North America and Europe, and growth in ARR, recurring revenue, and free cash flow. Management also sees acquisitions as strategically expanding Sapiens into faster-growing P&C specialty underwriting and APAC life markets while supporting cross-sell and cloud conversion.
Near-term profitability will be diluted by the Candela and Advantage Go acquisitions, with management explicitly guiding to about negative $5 million profit impact at the midpoint and noting Advantage Go will remain loss-making through 2025. Revenue also depends on uncertain acquisition close timing and FX, and management flagged potential tariff spillover risk if customers are affected, even though tariffs do not directly impact Sapiens today.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 54.8%
- Shares Outstanding
- 55.90M
- Float Shares
- 30.66M
of shares held by institutions
171 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Kryger Capital Ltd | 237.03K | ▲ 3.19K |
| Synovus Financial Corp | 114.06K | ▲ 21.57K |
| Nebula Research & Development LLC | 10.25K | ▼ 2.11K |
| Lindbrook Capital, LLC | 174 | ▼ 14 |
Held by 15 ETFs
Biggest fund positions in SPNS by dollar value.
Our SPNS coverage
Recent articles, reports, and earnings notes.
No research on SPNS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPNS report →Contrasting Code Rebel (OTCMKTS:CDRBQ) and Sapiens International (NASDAQ:SPNS)
defenseworld.net · Jan 19
Hamamatsu Photonics KK: A Significant Addition to Oakmark Intl Small Cap's Portfolio
gurufocus.com · Nov 25
Aviva PLC Sells 5,777 Shares of Sapiens International Corporation N.V. $SPNS
defenseworld.net · Nov 14
Sapiens (SPNS) Beats Q3 Earnings and Revenue Estimates
zacks.com · Nov 13
Sapiens Reports Third Quarter 2025 Financial Results
prnewswire.com · Nov 13
Chuck Royce's Strategic Moves: Significant Reduction in Air Lease Corp
gurufocus.com · Nov 12
SAPIENS TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025
prnewswire.com · Nov 6
Sapiens Customer Summit Highlighted Transformative Insurance Technology in Phoenix, Arizona
prnewswire.com · Oct 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.